Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Complex regional pain syndrome (CRPS) is a chronic pain condition that most often affects one limb usually after an injury. Symptoms include stiffness in affected joints, changes in nail and hair growth patterns, dystonia, and abnormal sweating pattern. Treatment includes bisphosphonates, non-steroidal anti-inflammatory drugs, opioids, and local anesthetic creams.
The Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) Drugs in Development market research report provides an overview of the Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) and features dormant and discontinued projects.
CRPS Pipeline Drugs Market Targets
The targets of the CRPS pipeline drugs market are Glutamate Ionotropic Receptor NMDA Type Subunit, Cannabinoid Receptor 2, Cannabinoid Receptor 1, Neuronal Acetylcholine Receptor Subunit Alpha 7, Synaptosomal Associated Protein 25, and Toll Like Receptor 4.
CRPS pipeline drugs market, by targets
For more target insights, download a free report sample
Mechanisms of Action of CRPS Pipeline Drugs Market
The mechanisms of action of the CRPS pipeline drugs market are Glutamate Ionotropic Receptor NMDA Type Subunit Antagonist, Cannabinoid Receptor 2 Agonist, Cannabinoid Receptor 1 Agonist, Neuronal Acetylcholine Receptor Subunit Alpha 7 Antagonist, Synaptosomal Associated Protein 25 Inhibitor, and Toll Like Receptor 4 Antagonist.
CRPS pipeline drugs market, by mechanisms of action
For more mechanisms of action insights, download a free report sample
Routes of Administration in CRPS Pipeline Drugs Market
The routes of administration in the CRPS pipeline drugs market are inhalational, oral, subcutaneous, intraarticular, intradermal, intramuscular, intraprostatic, parenteral, sublingual, and topical.
CRPS pipeline drugs market, by routes of administration
For more routes of administration insights, download a free report sample
Molecule Types in CRPS Pipeline Drugs Market
The molecule types in the CRPS pipeline drugs market are small molecule and protein.
CRPS pipeline drugs market, by molecule types
For more molecule type insights, download a free report sample
Key CRPS Pipeline Drugs Market Companies
Some of the key companies in the CRPS pipeline drugs market are Tetra Bio-Pharma Inc, AbbVie Inc, Bexson Biomedical Inc, Bio-Pharm Solutions Co Ltd, Biohaven Pharmaceutical Holding Company Ltd, iX Biopharma Ltd, NeuroTherpia Inc, PharmaTher Holdings Ltd, Soin Therapeutics LLC, and Tryp Therapeutics Inc.
CRPS pipeline drugs market, by key companies
To know more about key companies, download a free report sample
Market report overview
Targets | Glutamate Ionotropic Receptor NMDA Type Subunit, Cannabinoid Receptor 2, Cannabinoid Receptor 1, Neuronal Acetylcholine Receptor Subunit Alpha 7, Synaptosomal Associated Protein 25, and Toll Like Receptor 4 |
Mechanisms of Action | Glutamate Ionotropic Receptor NMDA Type Subunit Antagonist, Cannabinoid Receptor 2 Agonist, Cannabinoid Receptor 1 Agonist, Neuronal Acetylcholine Receptor Subunit Alpha 7 Antagonist, Synaptosomal Associated Protein 25 Inhibitor, and Toll Like Receptor 4 Antagonist |
Routes of Administration | Inhalational, Oral, Subcutaneous, Intraarticular, Intradermal, Intramuscular, Intraprostatic, Parenteral, Sublingual, and Topical |
Molecule Types | Small Molecule and Protein |
Key Companies | Tetra Bio-Pharma Inc, AbbVie Inc, Bexson Biomedical Inc, Bio-Pharm Solutions Co Ltd, Biohaven Pharmaceutical Holding Company Ltd, iX Biopharma Ltd, NeuroTherpia Inc, PharmaTher Holdings Ltd, Soin Therapeutics LLC, and Tryp Therapeutics Inc |
Scope
This report provides:
- A snapshot of the global therapeutic landscape of Complex Regional Pain Syndrome (Central Nervous System).
- Reviews of pipeline therapeutics for Complex Regional Pain Syndrome (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Pipeline products based on various stages of development ranging from pre-registration to discovery and undisclosed stages.
- Descriptive drug profiles for the pipeline products which include product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities.
- Reviews of key companies involved in Complex Regional Pain Syndrome (Central Nervous System) therapeutics and enlists all their major and minor projects.
- Evaluation of Complex Regional Pain Syndrome (Central Nervous System) targeted therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA), and molecule type.
- All the dormant and discontinued pipeline projects.
- Reviews of the latest news and deals related to pipeline therapeutics for Complex Regional Pain Syndrome (Central Nervous System).
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Complex Regional Pain Syndrome (Central Nervous System).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Complex Regional Pain Syndrome (Central Nervous System) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Bexson Biomedical Inc
Bio-Pharm Solutions Co Ltd
Biohaven Pharmaceutical Holding Company Ltd
iX Biopharma Ltd
NeuroTherpia Inc
PharmaTher Holdings Ltd
Soin Therapeutics LLC
Tetra Bio-Pharma Inc
Tryp Therapeutics Inc
Table of Contents
Table
Figures
Frequently asked questions
-
What are the targets of the CRPS pipeline drugs market?
The targets of the CRPS pipeline drugs market are Glutamate Ionotropic Receptor NMDA Type Subunit, Cannabinoid Receptor 2, Cannabinoid Receptor 1, Neuronal Acetylcholine Receptor Subunit Alpha 7, Synaptosomal Associated Protein 25, and Toll Like Receptor 4.
-
What are the mechanisms of action of the CRPS pipeline drugs market?
The mechanisms of action of the CRPS pipeline drugs market are Glutamate Ionotropic Receptor NMDA Type Subunit Antagonist, Cannabinoid Receptor 2 Agonist, Cannabinoid Receptor 1 Agonist, Neuronal Acetylcholine Receptor Subunit Alpha 7 Antagonist, Synaptosomal Associated Protein 25 Inhibitor, and Toll Like Receptor 4 Antagonist.
-
What are the routes of administration in the CRPS pipeline drugs market?
The routes of administration in the CRPS pipeline drugs market are inhalational, oral, subcutaneous, intraarticular, intradermal, intramuscular, intraprostatic, parenteral, sublingual, and topical.
-
What are the molecule types in the CRPS pipeline drugs market?
The molecule types in the CRPS pipeline drugs market are small molecule and protein.
-
Which are the key companies in the CRPS pipeline drugs market?
Some of the key companies in the CRPS pipeline drugs market are Tetra Bio-Pharma Inc, AbbVie Inc, Bexson Biomedical Inc, Bio-Pharm Solutions Co Ltd, Biohaven Pharmaceutical Holding Company Ltd, iX Biopharma Ltd, NeuroTherpia Inc, PharmaTher Holdings Ltd, Soin Therapeutics LLC, and Tryp Therapeutics Inc.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.